Investigation of muscle bioenergetics in the Marfan syndrome indicates reduced metabolic efficiency. by Crilley, J, Bendahan, D, Boehm, E, Styles, P, Rajagopalan, B, Wordsworth, P, Clarke, K

Endothelial dysfunction in the Marfan syndrome accelerates phosphocreatine depletion in early exercise: Implications for muscle fatigue in chronic heart failure by Crilley, J, Boehm, E, Bendahan, D, Rajagopalan, B, Styles, P, Wordsworth, P, Clarke, K

Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy. by Crilley, J, Boehm, E, Rajagopalan, B, Blamire, A, Styles, P, Muntoni, F, Hilton-Jones, D, Clarke, K

Chronic oral ascorbic acid therapy worsens skeletal muscle metabolism in patients with chronic heart failure. by Nightingale, A, Crilley, J, Pegge, N, Boehm, E, Mumford, C, Taylor, D, Styles, P, Clarke, K, Frenneaux, M

Muscular dystrophy: from gene to patient. by Hopkins, J, Bia, B, Crilley, J, Boehm, E, Sang, A, Tinsley, J, King, L, Radda, G, Davies, K, Clarke, K

Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. by Crilley, J, Boehm, E, Blair, E, Rajagopalan, B, Blamire, A, Styles, P, McKenna, W, Ostman-Smith, I, Clarke, K, Watkins, H

Despite improving endothelial function oral vitamin C increases phosphocreatine depletion during exercise in patients with chronic heart failure by Nightingale, A, Crilley, J, Pegge, N, Field, R, Schmitt, M, Mumford, C, Lee, L, Boehm, E, Taylor, D, Clarke, K, Styles, P, Frenneaux, M